Teva Pharmaceutical Industries Limited Sponsored ADRTeva Pharmaceutical Industries Limited Sponsored ADRTeva Pharmaceutical Industries Limited Sponsored ADR

Teva Pharmaceutical Industries Limited Sponsored ADR

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪17.61 B‬EUR
−0.118EUR
‪−1.58 B‬EUR
‪15.95 B‬EUR
‪1.15 B‬
Beta (1Y)
0.48

About Teva Pharmaceutical Industries Limited


CEO
Richard Francis
Headquarters
Tel Aviv
Founded
1901
ISIN
US8816242098
FIGI
BBG000D86RC8
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Check out other big names from the same industry as TEV.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.